SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Indoco Remedies - Quaterly Results

07 Nov 2025 Evaluate
The Revenue for the quarter ended  September 2025 of Rs. 4421.20 millions grew by 11.50 % from Rs. 3965.30 millions.Profit saw a slight increase of 17.67%to Rs. 150.50  millions from Rs. 127.90 millions.OP of the company witnessed a marginal growth to 599.30 millions from 570.70 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202503 202403 % Var
Sales 4421.20 3965.30 11.50 8346.50 7979.60 4.60 15181.90 17908.10 -15.22
Other Income 65.40 42.00 55.71 121.20 77.20 56.99 184.80 85.10 117.16
PBIDT 599.30 570.70 5.01 803.40 1121.60 -28.37 1465.20 2664.90 -45.02
Interest 220.10 147.70 49.02 456.20 266.50 71.18 566.30 368.20 53.80
PBDT 373.90 423.00 -11.61 341.90 855.10 -60.02 908.80 2412.00 -62.32
Depreciation 276.30 249.20 10.87 528.30 486.20 8.66 982.50 879.80 11.67
PBT 97.60 173.80 -43.84 -186.40 368.90 -150.53 -73.70 1532.20 -104.81
TAX -52.90 45.90 -215.25 -56.30 91.50 -161.53 13.60 365.80 -96.28
Deferred Tax -52.90 13.50 -491.85 -56.30 11.80 -577.12 13.60 38.10 -64.30
PAT 150.50 127.90 17.67 -130.10 277.40 -146.90 -87.30 1166.40 -107.48
Equity 184.50 184.40 0.05 184.50 184.40 0.05 184.50 184.40 0.05
PBIDTM(%) 13.56 14.39 -5.82 9.63 14.06 -31.52 9.65 14.88 -35.15

Indoco Remedies Share Price

228.20 -23.05 (-9.17%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×